Nezam H. Afdhal
Elite in Nonalcoholic Steatohepatitis (NASH)
Check Dr. Nezam H. Afdhal's experience treating your condition:
About Dr. Nezam H. Afdhal

Nezam Afdhal is a Gastroenterologist in Boston, Massachusetts. Afdhal has been practicing medicine for over 41 years and is rated as an Elite expert by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). He is also highly rated in 20 other conditions, according to our data. His top areas of expertise are Hepatitis C, Hepatitis, Cirrhosis, Nonalcoholic Steatohepatitis (NASH), and Liver Transplant. He is licensed to treat patients in Massachusetts. Afdhal is currently accepting new patients.

His clinical research consists of co-authoring 173 peer reviewed articles and participating in 9 clinical trials in the past 15 years. In particular, he has co-authored 31 articles and participated in 2 clinical trials in the study of Nonalcoholic Steatohepatitis (NASH).


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Nezam H. Afdhal it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
110 Francis St, Suite 8e, Boston, MA 02215
Background & Education
Graduate Institution
Other, 1981
Internal Medicine in MA
Hospital Affiliations
Beth Israel Deaconess Hospital - Milton
Milford Regional Medical Center
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Hospital - Needham
Beth Israel Deaconess Hospital - Plymouth
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Phase IV Study of Treatment of Acute Hepatitis C With Pegylated Interferon
A Study of the Cerebral Effect of Pegylated Interferon in Hepatitis C Positive Subjects
The Early Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Due to Portal Hypertension
Phase II, Randomized, Double-blind, Placebo-controlled Study of Nitazoxanide in Combination With Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Patients With Hepatitis C
Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy
View 8 Less Clinical Trials -

173 Total Publications

A phase 2, open-label, randomized, multiple dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B.

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors